What is the recommended treatment for panic attacks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Panic Attacks

The first-line treatment for panic attacks should be a combination of cognitive-behavioral therapy (CBT) and a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI), particularly for moderate to severe cases. 1

Recommended Treatment Approach

Psychotherapy

  • Cognitive-behavioral therapy (CBT) is the psychological treatment of first choice for panic attacks 1, 2
  • For individuals concerned about prior panic attacks, psychological treatment based on CBT principles is strongly recommended 3
  • Individual therapy is preferred over group therapy due to superior clinical and economic effectiveness 1

Pharmacotherapy

First-line medications:

  • SSRIs (e.g., paroxetine, sertraline) are the first-line pharmacological treatment 1, 4, 2
    • Start with 20 mg once daily of paroxetine, with titration range of 20-50 mg daily 1
    • Sertraline has proven effective in the range of 50-175 mg per day 5
  • SNRIs are also effective first-line options:
    • Venlafaxine is preferred for generalized anxiety disorder 1, 6
    • Duloxetine is preferred when comorbid pain conditions exist 1

Short-term/adjunctive medications:

  • Benzodiazepines (e.g., alprazolam) may be used for short-term treatment or in treatment-resistant cases 4, 2
    • Initial dose of alprazolam may be 0.5 mg three times daily, with careful titration up to a maximum of 4 mg daily in divided doses 7
    • For panic disorder specifically, doses of 1-10 mg daily have been used in clinical trials, with mean dosage of approximately 5-6 mg daily 7
    • Benzodiazepines should be reserved for patients without history of dependency and tolerance 4, 8
    • They can be combined with SSRIs in the first weeks of treatment before the onset of SSRI response 2

Treatment Algorithm

  1. For mild panic attacks with minimal functional impairment:

    • Begin with CBT alone 1
    • If inadequate response after 4-6 weeks, add an SSRI
  2. For moderate to severe panic attacks:

    • Begin with both CBT and an SSRI/SNRI simultaneously 1
    • Consider short-term benzodiazepine use (2-4 weeks) while waiting for SSRI/SNRI effect 2
  3. If first-line treatment is ineffective after 4-6 weeks:

    • Switch to another SSRI or SNRI 1
    • Consider increasing the dose of current medication
    • Intensify CBT

Monitoring and Treatment Duration

  • Assess response after 4-6 weeks of medication 1
  • Continue effective medication for at least 6-12 months after symptom remission 1
  • Taper medication gradually when discontinuing to avoid withdrawal symptoms 1, 7
    • For benzodiazepines like alprazolam, reduce by no more than 0.5 mg every 3 days 7
    • Some patients may require even slower tapering 7

Special Considerations

  • Elderly patients: Start with lower doses (e.g., alprazolam 0.25 mg two or three times daily) and titrate more slowly 1, 7
  • Patients with hepatic or renal impairment: Require dose adjustments and careful monitoring 1
  • Treatment-resistant cases: Reevaluate diagnosis, medication adherence, and consider alternative or augmentation strategies 1

Lifestyle Modifications

  • Establish a consistent morning routine
  • Regular exercise, particularly in the morning
  • Good sleep hygiene
  • Limit screen time before bed and after waking
  • Spend time in nature
  • Practice mindfulness and meditation 1

Common Pitfalls to Avoid

  • Prescribing benzodiazepines as first-line treatment for long-term use
  • Stopping medications abruptly, particularly benzodiazepines
  • Failing to combine pharmacotherapy with CBT, which is the most successful treatment strategy 4
  • Not monitoring for side effects, particularly during the initial treatment phase
  • Inadequate duration of treatment leading to symptom recurrence

References

Guideline

Treatment of Anxiety Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of panic disorder.

Expert review of neurotherapeutics, 2005

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacological treatment of panic disorder.

Modern trends in pharmacopsychiatry, 2013

Research

Sertraline in the treatment of panic disorder.

Drugs of today (Barcelona, Spain : 1998), 2009

Research

Venlafaxine in the treatment of panic disorder.

Neuropsychiatric disease and treatment, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.